Abstract
Fas, a type I membrane protein that transduces an apoptotic signal, is expressed in lymphocytes as well as in various tissues such as the liver, lung and heart. The mouse lymphoproliferation (lpr) mutation is a leaky mutation in Fas. By means of gene targeting, we generated a mouse strain which is completely deficient in Fas. In addition to the massive production of lymphocytes, the Fas–null mice showed substantial liver hyperplasia, which was accompanied by the enlargement of nuclei in hepatocytes. The Fas system seems to play a role in the apoptotic process to maintain homeostasis of the liver as well as the peripheral lymphoid organs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ellis, R.E., Yuan, J. & Horvitz, H.R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663–698 (1991).
Raff, M.C. Social controls on cell survival and cell death. Nature 356, 397–400 (1992).
Itoh, N. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233–243 (1991).
Oehm, A. et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. biol. Chem. 267, 10709–10715 (1992).
Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274–1279 (1992).
Suda, T., Takahashi, T., Golstein, R. & Nagata, S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75, 1169–1178 (1993).
Yonehara, S., Ishii, A. & Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. exp. Med. 169, 1747–1756 (1989).
Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301–305 (1989).
Suda, T. et al. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154, 3806–3813 (1995).
Vignaux, F. et al. TCR/CD3 coupling to Fas-based cytotoxicity. J. exp. Med. 181, 781–786 (1995).
Kägi, D. et al. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528–530 (1994).
Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650–652 (1994).
Rouvier, E., Luciani, M.-F. & Golstein, R. Fas involvement in Ca2+− independent T cell-mediated cytotoxicity. J. exp. Med. 177, 195–200 (1993).
Alderson, M.R. et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. exp. Med. 181, 71–77 (1995).
Ju, S.-T. et al. Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 373, 444–448 (1995).
Russell, J.H., Rush, B., Weaver, C. & Wang, R. Mature T cells of autoimmune Ipr/lprmice have a defect in antigen-stimulated suicide. Proc. natn. Acad. Sci. U.S.A. 90, 4409–4413 (1993).
Singer, G.G. & Abbas, A.K., Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365–371 (1994).
Nagata, S. & Suda, T. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 16, 39–43 (1995).
Nagata, S. & Golstein, P., Fas death factor. Science 267, 1449–1456 (1995).
Adachi, M., Watanabe-Fukunaga, R. & Nagata, S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc. natn. Acad. Sci. U.S.A. 90, 1756–1760 (1993).
Kobayashi, S., Hirano, T., Kakinuma, M. & Uede, T. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune LPR mice. Biochem. biophys. Res. Commun. 191, 617–624 (1993).
Chu, B.J.-L., Drappa, J., Parnassa, A. & Elkon, K.B. The defect in Fas mRNA expression in MRL/Ipr mice is associated with insertion of the retrotransposon, ETn. J. exp. Med. 178, 723–730 (1993).
Wu, J., Zhou, T., He, J. & Mountz, J.D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. exp. Med. 178, 461–468 (1993).
Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).
Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994).
Mariani, S.M., Matiba, B., Armandola, E.A. & Krammer, R.H., APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24, 3119–3123 (1994).
Cohen, R.L. & Eisenberg, R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243–269 (1991).
Ni, R. et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215, 332–337 (1995).
Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
Itoh, N. & Nagata, S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. biol. Chem. 268, 10932–10937 (1993).
Yagi, T. et al. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214, 77–86 (1993).
Izui, S. et al. Induction of various autoantibodies by mutant gene Ipr in several strains of mice. J. Immunol. 133, 227–233 (1984).
Ogasawara, J., Suda, T. & Nagata, S. Selective apoptosis of CD4+ CD8+ thymocytes by the anti-Fas antibody. J. exp. Med. 181, 485–491 (1995).
Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129–1135 (1995).
Benedetti, A., Jezequel, A.M. & Orlandi, F. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J. Hepatol. 7, 319–324 (1988).
Benedetti, A., Jezequel, A.M. & Orlandi, F. A quantitative evaluation of apoptotic bodies in rat liver. Liver 8, 172–177 (1988).
Arber, N., Zajicek, G. & Ariel, I. The streaming liver II. Hepatocyte life history. Liver 8, 80–87 (1988).
Andrew, W., Brown, H.M. & Johnson, J.B. Senile changes in the liver of mouse and man. Am. J. Anat. 72, 199–221 (1943).
Epstain, C.J. & Andrew, W. Nuclear ploidy in mammalian parenchyma! liver cells. Nature 214, 1050–1051 (1967).
McWhir, J., Selfridge, J., Harrison, D.J., Squires, S. & Melton, D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Alaftlre Genet. 5, 217–224 (1993).
Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).
Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995).
Tanaka, T. et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 353–361 (1995).
Friedrich, G. & Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5, 1513–1523 (1991).
Palmiter, R.D. et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435–443 (1987).
Mansour, S.L., Thomas, K.R. & Capecchi, M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348–352 (1988).
MacMahon, A.R. & Bradley, A., The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1037–1058 (1990).
Laird, R.W. et al. Simplified mammalian DNA isolation procedure. Nucl. Acids. Res. 19, 4293 (1991).
Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. exp. Med. 178, 1541–1554 (1993).
Watanabe, T., Katsura, Y., Yoshitake, A., Masataki, H. & Mori, T. IPAP: Image processor for analytical pathology. J. Toxicol. Pathol. 7, 353–361 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adachi, M., Suematsu, S., Kondo, T. et al. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11, 294–300 (1995). https://doi.org/10.1038/ng1195-294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1195-294
This article is cited by
-
Contribution of cell death signaling to blood vessel formation
Cellular and Molecular Life Sciences (2021)
-
Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease
Cell Death & Disease (2019)
-
The role of CD95 and CD95 ligand in cancer
Cell Death & Differentiation (2015)
-
Targeting Apoptosis in Autoimmune Hepatitis
Digestive Diseases and Sciences (2014)